Table 3.
Characteristics for Newly Diagnosed HIV Patients with No Missed Opportunities vs. Missed Opportunities for HIV Diagnosis in 2008–2011
| Characteristic | 0 Missed opportunities (n=29) | ≥1 Missed opportunities (n=72) | p Value | OR (95% CI) |
|---|---|---|---|---|
| Agea | ||||
| Mean±SD | 36.1±12.2 | 40.0±12.7 | 0.17 | 0.97 (0.94–1.01) |
| Gender | ||||
| Male (n=67) | 24 (82.8%) | 43 (59.7%) | 0.027 | 3.24 (1.11–9.46) |
| Female (n=34) | 5 (17.2%) | 29 (40.3%) | ||
| Race | ||||
| Black (n=73) | 18 (62.1%) | 55 (76.4%) | 0.146 | 0.51 (0.20–1.28) |
| White (n=20) | 6 (20.7%) | 14 (19.4%) | ||
| Hispanic (n=8) | 5 (17.2%) | 3 (4.2%) | ||
| Insurance | ||||
| Uninsured (n=28) | 11 (37.9%) | 17 (23.6%) | 0.146 | 1.98 (0.78–4.99) |
| Insured (n=73) | 18 (62.1%) | 55 (76.4%) | ||
| Mode of HIV acquisition | ||||
| MSM (n=24) | 9 (31.0%) | 15 (20.8%) | 0.276 | 1.71 (0.65–4.51) |
| Heterosexual (n=57) | 12 (41.4%) | 45 (62.5%) | ||
| IVDU (n=4) | 2 (6.9%) | 2 (2.8%) | ||
| Otherb/unknown (n=16) | 6 (20.7%) | 10 (13.9%) | ||
| Site of diagnosis | ||||
| Outpatient (n=73) | 22 (75.9%) | 51 (70.8%) | 0.610 | 1.29 (0.48–3.49) |
| Inpatient (n=28) | 7 (24.1%) | 21 (29.2%) | ||
| Persons w/ OI at diagnosis (n=15) | 3 (10.3%)c | 12 (16.7%)d | 0.419 | 0.58 (0.15–2.17) |
| CD4 lymphocyte count | ||||
| <200 cells/μL (n=33) | 9 (31.0%) | 24 (33.3%) | 0.823 | 0.90 (0.36–2.27) |
| HIV RNA | ||||
| >100,000 copies/mL (n=38) | 9 (31.0%) | 29 (40.3%) | 0.386 | 0.67 (0.27–1.67) |
a
Odds ratio for 10-year increase in age; bother: transgender, bisexual; copportunistic infections: esophageal candidiasis (n=2); Pneumocystis jirovecii pneumonia (n=1). dOIs: CNS toxoplasmosis (n=1); cryptococcal meningitis (n=1); esophageal candidiasis (n=2); Mycobacterium avium complex (n=1); Pneumocystis jirovecii pneumonia (n=8); recurrent severe bacterial infections (n=1).